Frankfurt - Delayed Quote EUR
NovoCure Limited (038.F)
15.97
+1.12
+(7.54%)
At close: April 25 at 3:49:30 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-30,460
-26,369
-73,336
30,788
82,756
Investing Cash Flow
-392,930
-140,242
184,148
-139,957
-144,834
Financing Cash Flow
95,349
90,315
15,787
15,491
25,702
End Cash Position
129,322
166,094
242,564
115,834
209,609
Income Tax Paid Supplemental Data
25,520
23,463
13,665
5,480
3,110
Interest Paid Supplemental Data
10,357
7,714
6
41
101
Capital Expenditure
-41,682
-42,855
-27,093
-21,358
-24,170
Issuance of Capital Stock
4,150
4,150
4,416
5,224
4,546
Issuance of Debt
96,922
96,922
--
--
--
Repayment of Debt
-12,913
-12,913
-10
-28
-26
Free Cash Flow
-72,142
-69,224
-100,429
9,430
58,586
12/31/2021 - 10/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade